Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue ablation via photothermal effect refers to a **physical process** rather than a specific molecular target. It involves the use of laser or other light sources whose energy is absorbed by endogenous chromophores (such as hemoglobin and melanin) or exogenous agents like gold nanoparticles. The absorbed energy is converted into heat, resulting in localized temperature increases that cause **cellular destruction through mechanisms such as vaporization, coagulation, necrosis, or apoptosis**. This method is widely used for ablating cancerous tumors and biofilms and has applications in dentistry and surgery for precise soft and hard tissue removal[3][4][5]. The specificity can be enhanced using nanoparticle-mediated delivery systems that localize heating effects within pathological tissues while sparing healthy structures[1][2][7]. However, "tissue ablation via photothermal effect" does not refer to a discrete protein/receptor/enzyme but rather describes a therapeutic modality; thus it should not be classified as a canonical drug target. > "Photothermal effects occur when the chromophores absorb the laser energy and heat is generated. This heat directly vaporizes the tissue and is used to incise or remove tissues... Photothermal interactions predominate when most soft tissue procedures are performed with dental lasers."[3] > "Photothermal therapy utilizes nanoparticles embedded within tumors as exogenous energy absorbers to convert laser light energy into heat to ablate cancer cells... PTT can be modulated to induce apoptosis rather than necrosis..."[1] Because this entry describes a **therapeutic technique**, not an individual molecular entity suitable for structured drug-target databases, it should be flagged as incorrect under standard target curation guidelines.
Conversion of absorbed light energy into heat by chromophores or exogenous agents, leading to thermal destruction and cell death in targeted tissues[3][4][5].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue ablation via photothermal effect.